Research Awards Listing
Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.
The Foundation provides the best and brightest minds with the resources and flexibility to pursue science of the highest quality. To date, we have committed more than $22 million for the study of pancreatic cancer research. What began as a small but dedicated community of pancreatic cancer researchers is now a critical mass of investigators with shared interest in the disease.
Listing By Area
Biology & Genetics
Aston University, United Kingdom
Michael J. Tisdale, DSc., Ph.D.
Mechanism of Muscle Protein Catabolism in Cancer Cachexia
Beth Israel Deaconess Medical Center
Hava Avraham, Ph.D.
Studies of CHK Kinase in Pancreatic Cancer Cells
Cold Spring Harbor Laboratory
Robert Lucito, Ph.D.
Genomic Analysis of Pancreatic Cancer Using DNA Microarrays
Creighton University School of Medicine
Thomas Adrian, Ph.D.
LOX Inhibitors for Pancreatic Cancer Treatment and Prevention
Columbia University
Argiris Efstratiadis, M.D., Ph.D.
Development of a Mouse Model of Pancreatic Cancer
Columbia University, College of Physicians and Surgeons
Paul B. Fisher, Ph.D.
Exploiting Defects in Molecular Circuitry to Selectively Kill Pancreatic Cancer Cells
Dana-Farber Cancer Institute
Nabeel Bardeesy, Ph.D.
Preclinical Model System for Kras Directed Pancreatic Tumor Maintenance and Biomarker Identification
Dana-Farber Cancer Institute
Nabeel Bardeesy, Ph.D.
Pancreatic Cancer Models for The Identification of Biomarkers and Tumor Maintenance Programs
Dana-Farber Cancer Institute / Harvard Medical School
Lynda Chin, M.D.
Comprehensive View of Pancreatic Cancer Oncogenomics
Dartmouth College
Catherine Carrière, Ph.D.
Adult Pancreatic Progenitor Cells as Targets of Oncogenic Events
Georgetown University Medical Center
Anna Riegel, Ph.D.
The Role of the Nuclear Receptor Coactivator AIB1in the Early Preneoplastic Stages of Pancreatic Cancer
Johns Hopkins Medical Institutions
Nita Ahuja, M.D.
Aberrant Hypermethylation of CpG Island Promoters in Pancreatic Cancer: Constructing a Hypermethylome
Johns Hopkins Medical Institutions
James Eshleman, M.D., Ph.D.
Pancreatic Cancer Tumor Suppressor Gene Discovery using RNAi
Johns Hopkins Medical Institutions
Anirban Maitra, MBBS
Genetic Basis of Familial Pancreatic Cancer: A Novel Approach Using Whole Genome Conversion and High-Throughput Oligonucleotide Microarrays
Johns Hopkins Medical Institutions
Anirban Maitra, MBBS
Synergistic Targeting of the Apoptotic Machinery in Pancreatic Cancer
Johns Hopkins Medical Institutions
Joshua Mendell, M.D., Ph.D.
The Role of MicroRNAs in the Pathogenesis of Pancreatic Cancer
Johns Hopkins Medical Institutions
Joshua Mendell, M.D., Ph.D.
Ras-Regulated MicroRNAs in Pancreatic Cancer
Johns Hopkins Medical Institutions
Gloria Su, Ph.D.
Identification of Tissue-Specific Promoters for Ductal Epithelium of Pancreas Using SAGE Libraries
Johns Hopkins Medical Institutions
Bert Vogelstein, M.D.
Sequencing the Genome of Pancreatic Cancers
Johns Hopkins Medical Institutions
Bert Vogelstein, M.D.
Development of Novel Diagnostic Approaches for the Early Detection of Pancreatic Neoplasms
Massachusetts General Hospital
Sarah Thayer, M.D., Ph.D.
Shh Links Chronic Inflammatory Injury to Pancreatic Carcinogenesis
Massachusetts General Hospital / Harvard Medical School
Sarah Thayer, M.D., Ph.D.
To Characterize the Contribution of Sonic Hedgehog to Pancreatic Neoplasia
Mayo Clinic at Rochester
Raul Urrutia, M.D.
Role of Novel Sp1-like Proteins in the Transcriptional Silencing Carcinogen-activating Enzymes in Exocrine Pancreatic Cells
Meharry Medical College and Vanderbilt University
Ana M. Grau, M.D.
Role of Rhob in Tumorigenesis and Metastasis In Pancreatic Cancer
Mt. Sinai Hospital, Toronto / Samuel Lunenfeld Research Institute
Steven Gallinger, M.D.
A Novel Pancreatic Cancer Tumor Suppressor Candidate Gene
Northwestern University
Paul Grippo, Ph.D.
Dual Targeting of Mutant Kras And Muchin1 in Mice That Develop Human Like Panins
Purdue University
Stephen F. Konieczny, Ph.D.
Mist 1 Kras G12D Generated Pancreatic Cancer
Samuel Lunenfeld Research Institute
Steven Gallinger, M.D.
Characterization of Germline DNA Copy Number Variation in Familial Pancreas Cancer
Stanford University
Anson W. Lowe, M.D.
Characterizing the Gene-expression Profile of Human Pancreatic Cancers
Stanford University School of Medicine
Jonathan Pollack, M.D., Ph.D.
Locating Novel Pancreatic Cancer Genes with DNA Microarrays
Technical University of Munich
Roland Schmid, M.D.
Jens T. Svieke, M.D.
The Role of Notch Signaling in Pancreatic Cancer Development
University of California at Davis Cancer Center
Richard Bold, M.D.
Anti-apoptotic Signaling through the AKT Kinase in Pancreatic Cancer
University of California at San Francisco Cancer Center
Matthias Hebrok, Ph.D.
Embryonic Signaling Pathways in Pancreatic Cancer
University of Michigan
Craig Logsdon, Ph.D.
The Role of ATDC in Radioresistance of Pancreatic Adenocarcinoma
University of Michigan
Chandan Kumar, Ph.D.
Discovery of Recurrent Gene Fusions in Pancreatic Cancer Using High-Throughput Sequencing
University of North Carolina at Chapel Hill
Adrienne D. Cox, Ph.D.
Functional Consequences of Oncogenically Mutated Kras in Pancreatic Cancer
University of Texas M.D. Anderson Cancer Center
Lee Ellis, M.D.
Role of Neuropilin-1 in Pancreatic Cancer Growth and Angiogenesis AP-1 and Ras Signaling in Pancreatic Cancer Cells
University of Texas M.D. Anderson Cancer Center
Shrikanth A. G. Reddy, Ph.D.
AP-1 and Ras Signaling in Pancreatic Cancer Cells
University of Texas M.D. Anderson Cancer Center
Keping Xie, M.D., Ph.D.
Control of Pancreatic Cancer Metastasis by Modulating Tumor-associated Nitric Oxide Production
University of Texas at San Antonio
James Freeman, Ph.D.
TGF-B Type II Receptor Gene as a Target for the Antitumor Effect of Farnesyltransferace Inhibitors in Pancreatic Cancer
Top of Page
Early Detection & Screening
Canary Foundation
Brad Nelson, Ph.D.
The Pancreatic Cancer Biomarker Initiative
Dana-Farber Cancer Institute
James DeCaprio, M.D.
The Pancreatic Cancer Biomarker Initiative
Johns Hopkins Medical Institutions
Marcia Canto, M.D.
Screening for Early Pancreatic Neoplasia: a Multi-Center Study
Johns Hopkins Medical Institutions
Michael Goggins, M.D.
Detect Early Symptomless Pancreatic Cancer
Johns Hopkins Medical Institutions
Michael G. Goggins, M.D.
Proteomic Profiles of Pancreatic Cancer
Johns Hopkins Medical Institutions
Michael Goggins, M.D.
Proteomic Profiles of Pancreatic Juice for the Early Detection of Pancreatic Cancer
Johns Hopkins Medical Institutions
Michael Goggins, M.D.
Novel Strategies and Technologies for Identifying Familial Pancreatic Cancer Genes
Massachusetts General Hospital
Kimberly Kelly, Ph.D.
Development of Molecular Imaging Agents for Early Detection of Pancreatic Cancer
Massachusetts General Hospital
Kimberly A. Kelly, Ph.D.
Plectin-1 As A Biomarker for the Early Detection of Pancreatic Ductal Adenocarcinoma
Mayo Clinic College of Medicine
Janet Olsen, Ph.D.
Identification of Early Stage Pancreatic Cancer Biomarkers using LC-Dual ESI-FT-ICR Mass Spectrometry
Mayo Clinic at Rochester
Suresh T. Chari, M.D.
Serum Proteomics of Pancreatic Cancer- Induced Diabetes
Mayo Clinic
Amy Tang, Ph.D.
SIAH: A Novel Biomarker of Pancreatic Cancer Progression and Therapeutic Implications
Memorial Sloan-Kettering Cancer Center
Gary K. Schwartz, M.D.
Clinical Development of Flavorpiridol for Patients With Locally Advanced and Metastatic Pancreatic Cancer
Ohio State University
Thomas Schmittgen, Ph.D.
MicroRNA Profiling in Serum of Pancreatic Adenocarcinoma Patients
* Supported by a generous donation from Michael Rolfe Pancreatic Cancer Foundation
University of California at San Francisco
James D. Marks, M.D., Ph.D.
The Pancreatic Cancer Biomarker Initiative
University of Michigan Medical Center
Diane M. Simeone, M.D.
Development and Validation of Novel Biomarkers for Early Pancreatic Cancer Detection
University of Michigan Medical Center
Diane Simeone, M.D.
Pancreatic Cancer Stem Cells
Van Andel Research Institute
Brian B. Cao, M.D.
The Pancreatic Cancer Biomarker Initiative
Top of Page
Etiology & Epidemiology
Dana-Farber Cancer Institute
Charles Fuchs, M.D., M.P.H.
Prospective Study of Pancreatic Cancer Pathogenesis
Harvard School of Public Health
Eric J. Duell, Ph.D.
Gene-Environment Interactions in Pancreatic Adenocarcinoma
Johns Hopkins Medical Institutions
Constance Griffin, M.D.
Chromosome Analysis in Patients with Familial Pancreatic Cancer
Johns Hopkins Medical Institutions
Christine Iacobuzio-Donahue, M.D., Ph.D.
Towards a Comprehensive Understanding of Pancreas Cancer Through Gene Expression Profiling
Johns Hopkins Medical Institutions
Allison Klein, Ph.D.
Identification of Pancreatic Cancer Susceptibility Genes
Mayo Clinic College of Medicine
Fergus J. Couch, Ph.D.
Genetic Epidemiology of Novel Pancreatic Cancer Susceptibility Genes
Mayo Clinic at Rochester
Gloria M. Peterson, Ph.D.
Genetic Epidemiology of Pancreatic Cancer
University of Pittsburgh
David C. Whitcomb, M.D., Ph.D.
Identify Genes Which are Only Expressed in Pancreatic Cancer Cells [check this]
Top of Page
Scientific Modeling Systems
Columbia University
Timothy Wang, M.D.
Development of An Inflammation-Based Pancreatic Cancer Model and Exploration of the Origins of Pancreatic Cancer
Supported by a generous donation from The Lefkofsky Family Foundation
Johns Hopkins Medical Institutions
Steven D. Leach, M.D.
Notch Signaling in Pancreatic Cancer Precursors
Johns Hopkins Medical Institutions
Steven Leach, M.D.
Zebrafish Model of Early Pancreatic Cancer
Johns Hopkins Medical Institutions
Gloria Su, Ph.D.
Mouse Models for Human Pancreatic Cancer
Salk Institute for Biological Studies
Inder M. Verma, Ph.D.
A Novel Mouse Model of Pancreatic Cancer Using Lentiviral Vectors
State University of New York at Stony Brook
Dafna Bar-Sagi, Ph.D.
Analysis of Pancreatic Ductal Adenocarcinoma Progression in a Mouse Model of Hereditary Pancreatitis
University of California at San Francisco Cancer Center
Martin McMahon, Ph.D.
A Systematic, Genome-Wide Analysis of Gene Copy Number Alteration in Pancreatic Cancer Cells by Array CGH
University of Nebraska Medical Center/Eppley Cancer Research Institute
Michel Ouellette, Ph.D.
In-Vitro Models of Pancreatic Cancer Development
University of Pittsburgh Cancer Institute
Katherine Pogue-Geile, Ph.D.
Functional Identification of Pancreatic Tumor Suppressor Genes
University of Utah
Lewis Charles Murtaugh, Ph.D.
Interdependence of Notch and Kras Signaling in Pancreatic Tumorigenesis
Top of Page
Therapy
Aston University, United Kingdom
Michael Tisdale, Dsc., Ph.D.
Cloning and Expression of a Muscle Receptor for a Cancer Cachectic Factor
Cambridge Research Institute
David Tuveson, M.D., Ph.D.
Novel Anti-K-ras Strategies in Ductal Pancreatic Cancer
Dana-Farber Cancer Institute
David Frank, M.D., Ph.D.
Inhibition of STAT3 in the Targeted Therapy of Pancreatic Cancer
Dana-Farber Cancer Institute / Harvard Medical School
Muneesh Tewari, M.D., Ph.D.
A Synthetic Lethal Screen to Discover Tumor-Selective Drug Targets in Pancreatic Cancer
Duke University Medical Center
Douglas Tyler, M.D.
Immunotherapy of Pancreatic Cancer Using Dendritic Cells Pulsed with Antigen in the Form of Amplified Total Tumor R
Fred Hutchinson Cancer Research Center
Sunil Hingorani, M.D., Ph.D.
Oncogenic Kras as a Therapeutic Target for Pancreas Cancer
Johns Hopkins Medical Institutions
Elizabeth Jaffee, M.D.
Functional Genomic Approach to Identify Genes That are Pancreatic Cancer Immune Target
Johns Hopkins Medical Institutions
Elizabeth Jaffee, M.D.
A Phase II Study of an Allogeneic Gm-CSF Secreting Pancreatic Tumor Vaccine
Johns Hopkins Medical Institutions
Steven D. Leach, M.D.
High-Throughput, In-Vivo Screening for Novel Pancreatic Cancer Drugs Using the Zebrafish System
Johns Hopkins Medical Institutions
Anirban Maitra, MBBS
Hedgehog Inhibitors of Pancreatic Cancer
Johns Hopkins Medical Institutions
Anirban Maitra, MBBS
Targeting the Herpes Virus Entry Mediator (HVEM) As A Novel Therapeutic Strategy in Pancreatic Cancer
Massachusetts General Hospital
Jeffrey Settleman, Ph.D.
Identification and Validation of Novel Therapeutics for Kras-Mutant Pancreatic Cancer
Memorial Sloan-Kettering Cancer Center
Yuman Fong, M.D.
Synergy of Herpes Viruses with Chemotherapy or Immunotherapy in the Treatment of Pancreatic Cancer
Memorial Sloan-Kettering Cancer Center
Richard N. Kolesnick, M.D.
Development of KSR Phosphorothioate Antisense Oligonucleotides in the Treatment of Human Pancreatic Cancer
New York University School of Medicine
Daniel Meruelo, Ph.D.
Imaging-Assisted Design of Viral Vectors to Eradicate Metastatic Pancreatic Cancer
NYU School of Medicine
Steven Hofstetter, M.D.
Evaluation of Pancreatic Cancer Growth and Metastasis in Plasminogen Activator Deficient Mice
Stanford University
Albert Koong, M.D., Ph.D.
Selective Modulators of Protein Kinase C Activity as a Novel Class of Hypoxia Cell Cytotoxins in Human Pancreatic Cancer
Stanford University School of Medicine
Jonathan R. Pollack, M.D., Ph.D.
Locating Novel Pancreatic Cancer Genes With DNA Microarrays
SUNY Downstate Medical Center
Josef Michl, M.D.
Matthew R. Pincus, M.D., Ph.D.
Novel Methods in the Diagnosis and Treatment of Pancreatic Cancer
University of Alabama at Birmingham
David T. Curiel, M.D.
Pancreatic Carcinoma Specific Replicative Adenoviral Agent
University of Alabama at Birmingham
Pierre L. Triozzi, M.D.
ErbB Receptor Immunotherapy
University of California at San Francisco Cancer Center
Allan Balmain, Ph.D.
Therapeutic Approaches to Pancreatic Cancer Based on Kras Isoform 4A Expression in Stem Cells
University of California at San Francisco Cancer Center
Martin McMahon, Ph.D.
Targeting Kinases to Overcome Gemcitabine Resistance in Pancreatic Carcinoma
University of California at San Francisco Cancer Center
Margaret Tempero, M.D.
Optimizing Therapy for Pancreatic Adenocarcinoma with TALL-104 Cells
University of Pittsburgh Cancer Institute
Ramesh K. Ramanathan, M.D.
Co-Principal Investigator: Olivera Finn, Ph.D.
Phase I/II Study of a MUC-1 Pulsed Dendritic Cell Vaccine In Resected Pancreatic and Biliary Cancers
University of Texas M.D. Anderson Cancer Center
George Halder, Ph.D.
A Novel Genetic System to Identify Ideal Cancer Drug Targets in Pancreatic Cancer
University of Texas M.D. Anderson Cancer Center
David McConkey, M.D., Ph.D.
A Novel Therapy for Advanced Pancreatic Cancer
University of Washington
Teresa Brentnall, M.D.
Discovery of a Familial Pancreatic Cancer Gene
Top of Page